Two Sigma Advisers’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$425K Sell
34,700
-16,600
-32% -$203K ﹤0.01% 1819
2025
Q1
$735K Sell
51,300
-13,100
-20% -$188K ﹤0.01% 1609
2024
Q4
$1.03M Sell
64,400
-19,900
-24% -$317K ﹤0.01% 1450
2024
Q3
$2.03M Sell
84,300
-60,100
-42% -$1.44M ﹤0.01% 1053
2024
Q2
$2.88M Buy
144,400
+8,100
+6% +$161K 0.01% 1004
2024
Q1
$2.71M Sell
136,300
-4,200
-3% -$83.6K 0.01% 1062
2023
Q4
$3.15M Sell
140,500
-37,800
-21% -$848K 0.01% 1050
2023
Q3
$3.61M Buy
178,300
+54,600
+44% +$1.1M 0.01% 897
2023
Q2
$3.16M Sell
123,700
-19,000
-13% -$486K 0.01% 968
2023
Q1
$4.24M Sell
142,700
-57,000
-29% -$1.7M 0.01% 874
2022
Q4
$5.4M Sell
199,700
-39,400
-16% -$1.07M 0.02% 753
2022
Q3
$5.21M Sell
239,100
-35,200
-13% -$767K 0.02% 715
2022
Q2
$7.5M Sell
274,300
-30,400
-10% -$831K 0.02% 604
2022
Q1
$10.2M Buy
304,700
+7,800
+3% +$261K 0.03% 514
2021
Q4
$10.3M Sell
296,900
-18,500
-6% -$641K 0.03% 494
2021
Q3
$9.84M Buy
+315,400
New +$9.84M 0.03% 526
2019
Q3
Sell
-15,100
Closed -$659K 2223
2019
Q2
$659K Sell
15,100
-44,000
-74% -$1.92M ﹤0.01% 1699
2019
Q1
$2.52M Sell
59,100
-16,600
-22% -$708K 0.01% 1120
2018
Q4
$3.39M Sell
75,700
-4,317
-5% -$193K 0.01% 947
2018
Q3
$5.48M Sell
80,017
-11,600
-13% -$795K 0.01% 791
2018
Q2
$5.25M Buy
91,617
+11,600
+14% +$664K 0.01% 830
2018
Q1
$3.69M Buy
80,017
+15,800
+25% +$728K 0.01% 971
2017
Q4
$2.97M Hold
64,217
0.01% 1064
2017
Q3
$2.89M Buy
64,217
+28,800
+81% +$1.3M 0.01% 1034
2017
Q2
$1.39M Buy
35,417
+18,700
+112% +$734K ﹤0.01% 1374
2017
Q1
$637K Sell
16,717
-31,559
-65% -$1.2M ﹤0.01% 1789
2016
Q4
$1.79M Buy
48,276
+23,076
+92% +$853K 0.01% 1243
2016
Q3
$873K Buy
+25,200
New +$873K ﹤0.01% 1419
2015
Q3
Sell
-35,000
Closed -$1.42M 1802
2015
Q2
$1.42M Buy
+35,000
New +$1.42M 0.01% 954